Novo Nordisk and Eli Lilly rival soars 32% after promising weight loss drug results

Zealand Pharma’s Phase 2 trial was an “uniquivocal win” for a drug that can treat both liver disease and obesity, analysts said.
International: Top News And Analysis

World

Tagged after, drug, Lilly, loss, Nordisk, Novo, Promising, Results, rival, Soars, Weight

Lunar landing photos: Intuitive Machines’ Odysseus sends back first images from the moon

Jacob Rothschild, Banker, Financier and Philanthropist Dies at 87

Apple iPhone maker Foxconn wants to become the Android for electric cars with new vehicle platform

Foxconn, the Taiwan company that assembles Apple’s iPhone, has launched an platform to help automobile companies make electric cars. International: Top News And Analysis

Andrew Bailey selected to replace Mark Carney as the Bank of England governor

Andrew Bailey, the current head of the U.K.’s financial watchdog, has been named as the next governor of the Bank of England. International: Top News And Analysis

Stock futures are flat on Wednesday evening

Stock futures were flat in overnight trading Wednesday after the major averages ended the regular session lower and U.S. Treasury yields rose. International: Top News And Analysis

Your email address will not be published. Required fields are marked *

Comment *

Name *

Email *

Website

This Domain May Be For Sale

Related Posts

Leave a Reply